Oral versus intravenous iron therapy in patients with inflammatory bowel disease and iron deficiency with and without anemia in Germany - A real-world evidence analysis

ClinicoEconomics and Outcomes Research

Volumn 10, Issue , 2018, Pages 93-103

  Stein, Jürgen ^a,b   Haas, Jennifer Scarlet ^c   Ong, Siew Hwa ^d   Borchert, Kathrin ^c   Hardt, Thomas ^d   Lechat, Elmira ^d   Nip, Kerry ^d   Foerster, Douglas ^d   Braun, Sebastian ^c   Baumgart, Daniel C ^e  

^a Crohn Colitis Center Rhein Main   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c Xcenda GmbH   (Germany)

^d Vifor (International) Inc   (Switzerland)

^e UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Claims data; Germany; Health care cost; Inflammatory bowel disease; Iron treatment; Iron deficiency anemia

Indexed keywords

IRON;

ADOLESCENT; ADULT; AGED; ALL CAUSE HOSPITALIZATION; ARTICLE; CHILD; COST CONTROL; DRUG COST; DRUG DOSAGE FORM COMPARISON; FEMALE; FREQUENCY ANALYSIS; GERMANY; HEALTH CARE COST; HOSPITAL CARE; HOSPITALIZATION; HUMAN; INFLAMMATORY BOWEL DISEASE; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; IRON THERAPY; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT OUTCOME; VERY ELDERLY;

EID: 85041506228     PISSN: None     EISSN: 11786981     Source Type: Journal    
DOI: 10.2147/CEOR.S150900     Document Type: Article

References (39)

1. Camaschella C. Iron-deficiency anemia. N Engl J Med. 2015;372(19): 1832-1843.
2. Blumenstein I, Dignass A, Vollmer S, Klemm W, Weber-Mangal S, Stein J. Current practice in the diagnosis and management of IBD-associated anaemia and iron deficiency in Germany: the German AnaemIBD Study. J Crohns Colitis. 2014;8(10): 1308-1314.
3. Danese S, Hoffman C, Vel S, et al. Anaemia from a patient perspective in inflammatory bowel disease: results from the European Federation of Crohn’s and Ulcerative Colitis Association’s online survey. Eur J Gastroenterol Hepatol. 2014;26 (12): 1385-1391.
4. Rogler G, Vavricka S. Anemia in inflammatory bowel disease: an underestimated problem? Front Med. 2014;1: 58.
5. Martin J, Radeke HH, Dignass A, Stein J. Current evaluation and management of anaemia in patients with inflammatory bowel disease. Expert Rev Gastroenterol Hepatol. 2017;11(1): 19-32.
6. Lupu A, Diculescu M, Diaconescu R, et al. Prevalence of anemia and iron deficiency in Romanian patients with inflammatory bowel disease: a prospective multicenter study. J Gastrointestin Liver Dis. 2015;24(1): 15-20.
7. Koutroubakis IE, Ramos-Rivers C, Regueiro M, et al. Persistent or recurrent anemia is associated with severe and disabling inflammatory bowel disease. Clin Gastroenterol Hepatol. 2015;13(10): 1760-1766.
8. Filmann N, Rey J, Schneeweiss S, et al. Prevalence of anemia in inflammatory bowel diseases in European countries: a systematic review and individual patient data meta-analysis. Inflamm Bowel Dis.2014;20(5): 936-945.
9. Stein J, Hartmann F, Dignass AU. Diagnosis and management of iron deficiency anemia in patients with IBD. Nat Rev Gastroenterol Hepatol. 2010;7(11): 599-610.
10. Pratt JJ, Khan KS. Non-anaemic iron deficiency - a disease looking for recognition of diagnosis: a systematic review. Eur J Haematol.2016;96(6): 618-628.
11. Agarwal R. Nonhematological benef its of iron. Am J Nephrol.2007;27(6): 565-571.
12. Dignass AU, Gasche C, Bettenworth D, et al. European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases. J Crohns Colitis. 2015;9(3): 211-222.
13. World Health Organization (WHO). Iron Deficiency Anemia: Assessment, Prevention and Control - A Guide for Programme Managers. Geneva: WHO; 2001.
14. Van Assche G, Dignass A, Bokemeyer B, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis. 2013;7(1): 1-33.
15. Bager P, Befrits R, Wikman O, et al. Fatigue in out-patients with inflammatory bowel disease is common and multifactorial. Aliment Pharmacol Ther. 2012;35(1): 133-141.
16. Bager P, Befrits R, Wikman O, et al. High burden of iron deficiency and different types of anemia in inflammatory bowel disease outpatients in Scandinavia: a longitudinal 2-year follow-up study. Scand J Gastroenterol.2013;48(11): 1286-1293.
17. Wells CW, Lewis S, Barton JR, Corbett S. Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients. Inflamm Bowel Dis. 2006;12(2): 123-130.
18. Gasche C, Lomer MC, Cavill I, Weiss G. Iron, anaemia, and inflammatory bowel diseases. Gut. 2004;53(8): 1190-1197.
19. Bager P, Dahlerup JF. The health care cost of intravenous iron treatment in IBD patients depends on the economic evaluation perspective. J Crohns Colitis. 2010;4(4): 427-430.
20. Goldberg ND. Iron deficiency anemia in patients with inflammatory bowel disease. Clin Exp Gastroenterol 2013;6: 61-70.
21. Ott C, Liebold A, Takses A, Strauch UG, Obermeier F. High prevalence but insufficient treatment of iron-deficiency anemia in patients with inflammatory bowel disease: results of a population-based cohort. Gastroenterol Res Pract. 2012;2012: 595970.
22. Voegtlin M, Vavricka SR, Schoepfer AM, et al. Prevalence of anaemia in inflammatory bowel disease in Switzerland: a cross-sectional study in patients from private practices and university hospitals. J Crohns Colitis. 2010;4(6): 642-648.
23. Stein J, Bager P, Befrits R, et al. Anaemia management in patients with inflammatory bowel disease: routine practice across nine European countries. Eur J Gastroenterol Hepatol. 2013;25(12): 1456-1463.
24. Murphy GJ, Reeves BC, Rogers CA, Rizvi SI, Culliford L, Angelini GD. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation. 2007;116(22): 2544-2552.
25. Kim KO. Management of anemia in patients with inflammatory bowel disease. Korean J Gastroenterol. 2015;65(3): 145.
26. Lee TW, Kolber MR, Fedorak RN, van Zanten SV. Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: a systematic review and meta-analysis. J Crohns Colitis. 2012;6(3): 267-275.
27. Baumgart DC, le Claire M. The expenditures for academic inpatient care of inflammatory bowel disease patients are almost double compared with average academic gastroenterology and hepatology cases and not fully recovered by diagnosis-related group (DRG) proceeds. PLoS One. 2016;11(1): e0147364.
28. Wilson A, Reyes E, Ofman J. Prevalence and outcomes of anemia in inflammatory bowel disease: a systematic review of the literature. Am J Med. 2004;116 (Suppl 7A): 44S-49S.
29. Kulnigg S, Gasche C. Systematic review: managing anaemia in Crohn’s disease. Aliment Pharmacol Ther. 2006;24(11-12): 1507-1523.
30. Andersohn F, Walker J. Characteristics and external validity of the German Health Risk Institute (HRI) Database. Pharmacoepidemiol Drug Saf. 2016;25(1): 106-109.
31. Dimick JB, Ryan AM. Methods for evaluating changes in health care policy: the difference-in-differences approach. JAMA. 2014;312(22): 2401-2402.
32. Zhou H, Taber C, Arcona S, Li Y. Difference-in-differences method in comparative effectiveness research: utility with unbalanced groups. Appl Health Econ Health Policy. 2016;14(4): 419-429.
33. Stokes J, Kristensen SR, Checkland K, Bower P. Effectiveness of multidisciplinary team case management: difference-in-differences analysis. BMJ Open. 2016;6(4): e010468.
34. Stuart EA, Huskamp HA, Duckworth K, et al. Using propensity scores in difference-in-differences models to estimate the effects of a policy change. Health Serv Outcomes Res Methodol. 2014;14(4): 166-182.
35. Gebel M, Vossemer J. The impact of employment transitions on health in Germany. A difference-in-differences propensity score matching approach. Soc Sci Med. 2014;108: 128-136.
36. Gisbert JP, Gomollon F. Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease. Am J Gastroenterol. 2008;103(5): 1299-1307.
37. Ershler WB, Chen K, Reyes EB, Dubois R. Economic burden of patients with anemia in selected diseases. Value Health. 2005;8(6): 629-638.
38. Patel MS, Volpp KG, Small DS, et al. Association of the 2011 ACGME resident duty hour reforms with mortality and readmissions among hospitalized medicare patients. JAMA. 2014;312(22): 2364-2373.
39. Rajaram R, Chung JW, Jones AT, et al. Association of the 2011 ACGME resident duty hour reform with general surgery patient outcomes and with resident examination performance. JAMA. 2014;312(22): 2374-2384.